Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
暂无分享,去创建一个
Jeffrey N. Martin | D. Waters | J. McCune | E. Sinclair | S. Deeks | P. Hsue | B. Bredt | P. Hunt | M. Killian | R. Hoh | Arlana Franklin | Jeffrey N. Martin
[1] W. K. Henry,et al. Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure , 2005, AIDS.
[2] R. Kronmal,et al. Azithromycin for the secondary prevention of coronary events. , 2005, The New England journal of medicine.
[3] Charles E. McCulloch,et al. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .
[4] V. Maino,et al. Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.
[5] B. Coll,et al. Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele , 2004, Circulation.
[6] S. Josefowicz,et al. CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals. , 2004, Viral immunology.
[7] Peter Hunt,et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.
[8] Jeffrey N. Martin,et al. Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection , 2004, Circulation.
[9] Tao Dong,et al. Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection , 2004, PLoS biology.
[10] D. Waters,et al. Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection , 2004, Circulation.
[11] Jeffrey N. Martin,et al. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. , 2004, The Journal of infectious diseases.
[12] D. Costagliola,et al. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men , 2003, AIDS.
[13] Todd M. Allen,et al. Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus Sequences , 2003, Journal of Virology.
[14] A. Simon,et al. Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients. , 2003, Journal of acquired immune deficiency syndromes.
[15] S. Kaul,et al. Acute myocardial infarction in human immunodeficiency virus-infected patients. , 2003, Archives of internal medicine.
[16] S. Rowland-Jones,et al. Premature ageing of the immune system: the cause of AIDS? , 2002, Trends in immunology.
[17] John M Williamson,et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1 , 2002, The Lancet.
[18] A. Telenti,et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. , 2002, Blood.
[19] S. Sidney,et al. Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV‐1 Infection? , 2002, Journal of acquired immune deficiency syndromes.
[20] J. Kahn,et al. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion. , 2002, Journal of acquired immune deficiency syndromes.
[21] C. Tinelli,et al. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. , 2002, Atherosclerosis.
[22] S. Hunt,et al. IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone , 2001, Transplantation.
[23] J. McCune,et al. The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.
[24] A. Telenti,et al. Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy , 2001, AIDS.
[25] D. Nixon,et al. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. , 2001, Virology.
[26] G. Serio,et al. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors , 2000, AIDS.
[27] B. Horne,et al. Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease , 2000, Circulation.
[28] H. Schuitemaker,et al. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.
[29] R. Loire,et al. Accelerated coronary atherosclerosis and arteriosclerosis in young human‐immunodeficiency‐virus‐positive patients , 2000, Coronary artery disease.
[30] T. Merigan,et al. Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. , 1999, Circulation.
[31] J V Giorgi,et al. Quantitation of CD38 expression using QuantiBRITE beads. , 1998, Cytometry.
[32] R. Detels,et al. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[33] D. Ho,et al. HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy , 1998, The Journal of experimental medicine.
[34] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[35] C. Pitcher,et al. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.
[36] M. Leon,et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. , 1996, The New England journal of medicine.
[37] D. Weissman,et al. The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation , 1996, The Journal of experimental medicine.
[38] M. Daemen,et al. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. , 1995, Circulation.
[39] A. Folsom,et al. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study. , 1992, Annals of epidemiology.
[40] L. Chambless,et al. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. , 1991, American journal of epidemiology.
[41] R. Detels,et al. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. , 1989, Clinical immunology and immunopathology.
[42] V. Starnes,et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. , 1989, JAMA.
[43] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[44] Rodolphe Thiébaut,et al. Combination antiretroviral therapy and the risk of myocardial infarction , 2003 .
[45] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[46] W. Roos,et al. Development of a new microparticle‐enhanced turbidimetric assay for C‐reactive protein with superior features in analytical sensitivity and dynamic range , 1998, Journal of clinical laboratory analysis.
[47] S. Chou,et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[48] M. V. van Dam-Mieras,et al. The possible role of cytomegalovirus in atherogenesis. , 1991, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.